Marshall Wace’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.29M Buy
419,497
+237,307
+130% +$1.03M ﹤0.01% 2013
2025
Q4
$649K Hold
182,190
﹤0.01% 2134
2025
Q3
$1.62M Hold
182,190
﹤0.01% 1716
2025
Q2
$1.68M Hold
182,190
﹤0.01% 1643
2025
Q1
$1.56M Buy
182,190
+41,071
+29% +$388K ﹤0.01% 1579
2024
Q4
$1.52M Buy
+141,119
New +$1.09M ﹤0.01% 1552
2024
Q3
Sell
-39,351
Closed -$166K 2501
2024
Q2
$166K Buy
+39,351
New +$159K ﹤0.01% 2332
2023
Q4
Sell
-156,078
Closed -$1.02M 2181
2023
Q3
$1.02M Buy
156,078
+144,779
+1,281% +$1.15M ﹤0.01% 1498
2023
Q2
$91.9K Sell
11,299
-36,401
-76% -$312K ﹤0.01% 2333
2023
Q1
$409K Buy
47,700
+12,704
+36% +$127K ﹤0.01% 2181
2022
Q4
$324K Buy
+34,996
New +$374K ﹤0.01% 2536
2022
Q3
Sell
-423,636
Closed -$4.24M 3341
2022
Q2
$4.24M Buy
423,636
+378,278
+834% +$3.58M 0.01% 1463
2022
Q1
$558K Buy
+45,358
New +$558K ﹤0.01% 2725
2021
Q2
Sell
-163,087
Closed -$2.44M 2645
2021
Q1
$2.44M Buy
+163,087
New +$1.78M 0.01% 1219

Other funds holding AVXL